Owning the Risk Managing Raw Material Qualification when Suppliers Fall Short
- Understanding the level of due diligence required when using research-use-only or poorly documented reagents in clinical and commercial manufacturing
- Navigating practical strategies for tracing raw material quality and risk down to secondary and tertiary component levels when suppliers provide limited data
- Developing internal qualification frameworks and risk assessments to ensure regulatory readiness, despite inconsistent or incomplete supplier documentation